Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

[Lyme Borreliosis: Cutaneous and Neurologic Manifestations, Case Definitions and Therapy].

Scheerer C, Dersch R, Huppertz HI, Hofmann H.

Dtsch Med Wochenschr. 2020 Jan;145(1):19-28. doi: 10.1055/a-0793-4513. Epub 2020 Jan 8. German.

PMID:
31914465
2.

Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort Study.

Nordal E, Pistorio A, Rygg M, Giancane G, Maghnie M, Di Iorgi N, Flemming K, Hofer M, Melo-Gomes JA, Bica BERG, Brunner J, Dannecker G, Gerloni V, Harjacek M, Huppertz HI, Pratsidou-Gertsi P, Nielsen S, Stanevicha V, Ten Cate R, Vougiouka O, Pastore S, Simonini G, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation.

Arthritis Care Res (Hoboken). 2020 Feb;72(2):265-273. doi: 10.1002/acr.24065.

PMID:
31507092
3.

[Pediatric and adolescent rheumatology-A rapidly developing field in pediatrics : Current status of juvenile idiopathic arthritis and juvenile dermatomyositis].

Huppertz HI, Minden K.

Z Rheumatol. 2019 Sep;78(7):585-586. doi: 10.1007/s00393-019-0675-y. German. No abstract available.

PMID:
31482211
4.

Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial.

Mallalieu NL, Wimalasundera S, Hsu JC, Douglass W, Wells C, Penades IC, Cuttica R, Huppertz HI, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C.

Pediatr Rheumatol Online J. 2019 Aug 22;17(1):57. doi: 10.1186/s12969-019-0364-z.

5.

The German National Registry of Primary Immunodeficiencies (2012-2017).

El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt RE, Schürmann G, Sogkas G, Baumann UH, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch LG, Scheibenbogen CM, Wittke K, Albert MH, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger FM, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller AH, Ülzen A, Bader P, Bakhtiar S, Lee JY, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws HJ, Neubert J, Oommen PT, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing MT, Schwaneck EC, Tony HP, Dirks J, Haase G, Liese JG, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Mohr M, Geberzahn L, Hedrich CM, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh JK, Schwarze-Zander C, Wasmuth JC, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz HI, Kaiser-Labusch P, Greil J, Jakoby D, Kulozik AE, Metzler M, Naumann-Bartsch N, Sobik B, Graf N, Heine S, Kobbe R, Lehmberg K, Müller I, Herrmann F, Horneff G, Klein A, Peitz J, Schmidt N, Bielack S, Groß-Wieltsch U, Classen CF, Klasen J, Deutz P, Kamitz D, Lassay L, Tenbrock K, Wagner N, Bernbeck B, Brummel B, Lara-Villacanas E, Münstermann E, Schneider DT, Tietsch N, Westkemper M, Weiß M, Kramm C, Kühnle I, Kullmann S, Girschick H, Specker C, Vinnemeier-Laubenthal E, Haenicke H, Schulz C, Schweigerer L, Müller TG, Stiefel M, Belohradsky BH, Soetedjo V, Kindle G, Grimbacher B.

Front Immunol. 2019 Jul 19;10:1272. doi: 10.3389/fimmu.2019.01272. eCollection 2019.

6.

Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis.

Pardeo M, Wang J, Ruperto N, Alexeeva E, Chasnyk V, Schneider R, Horneff G, Huppertz HI, Minden K, Onel K, Zemel L, Martin A, Koné-Paut I, Siamopoulou-Mavridou A, Silva CA, Porter-Brown B, Bharucha KN, Brunner HI, De Benedetti F; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

J Rheumatol. 2019 Sep;46(9):1117-1126. doi: 10.3899/jrheum.180795. Epub 2019 Mar 1.

7.

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study.

Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, Bovis F, De Inocencio J, Demirkaya E, Flato B, Foell D, Garay SM, Lazăr C, Lovell DJ, Montobbio C, Miettunen P, Mihaylova D, Nielsen S, Orban I, Rumba-Rozenfelde I, Magalhães CS, Shafaie N, Susic G, Trachana M, Wulffraat N, Pistorio A, Martini A, Ruperto N, Ravelli A; Paediatric Rheumatology International Trials Organisation.

Lancet Child Adolesc Health. 2019 Apr;3(4):255-263. doi: 10.1016/S2352-4642(19)30027-6. Epub 2019 Feb 26.

PMID:
30819662
8.

Lyme Neuroborreliosis.

Rauer S, Kastenbauer S, Fingerle V, Hunfeld KP, Huppertz HI, Dersch R.

Dtsch Arztebl Int. 2018 Nov 9;115(45):751-756. doi: 10.3238/arztebl.2018.0751.

9.

[Adolescent rheumatology].

Huppertz HI, Villiger P.

Z Rheumatol. 2018 Oct;77(8):649-650. doi: 10.1007/s00393-018-0520-8. German. No abstract available.

PMID:
30264244
10.

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Holzinger D, Foell D, Horneff G, Foeldvari I, Tzaribachev N, Tzaribachev C, Minden K, Kallinich T, Ganser G, Clara L, Haas JP, Hügle B, Huppertz HI, Weller F, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):211-218. doi: 10.1007/s00296-018-3953-0. Epub 2018 Apr 7.

11.

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.

Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rösen-Wolff A, Minden K, Szymanski AM; INCHARGE Consortium, Thomson W, Kastner DL, Woo P, Ombrello MJ.

Arthritis Rheumatol. 2018 Aug;70(8):1319-1330. doi: 10.1002/art.40498. Epub 2018 Jun 28.

12.

Identification of an Amino Acid Motif in HLA-DRβ1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis.

Haasnoot AJW, Schilham MW, Kamphuis S, Hissink Muller PCE, Heiligenhaus A, Foell D, Minden K, Ophoff RA, Radstake TRDJ, Den Hollander AI, Reinards THCM, Hiddingh S, Schalij-Delfos NE, Hoppenreijs EPAH, van Rossum MAJ, Wouters C, Saurenmann RK, van den Berg JM, Wulffraat NM; ICON-JIA Study Group, Ten Cate R, de Boer JH, Pulit SL, Kuiper JJW.

Arthritis Rheumatol. 2018 Jul;70(7):1155-1165. doi: 10.1002/art.40484. Epub 2018 May 29.

13.

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson AF, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach A, Huppertz HI, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project collaborators.

Pediatr Rheumatol Online J. 2018 Jan 22;16(1):7. doi: 10.1186/s12969-018-0224-2.

14.

Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).

de Hoog MLA, Vesikari T, Giaquinto C, Huppertz HI, Martinon-Torres F, Bruijning-Verhagen P.

Hum Vaccin Immunother. 2018 Apr 3;14(4):1027-1034. doi: 10.1080/21645515.2017.1412019. Epub 2018 Jan 18.

15.

Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.

Hofmann H, Fingerle V, Hunfeld KP, Huppertz HI, Krause A, Rauer S, Ruf B; Consensus group.

Ger Med Sci. 2017 Sep 5;15:Doc14. doi: 10.3205/000255. eCollection 2017.

16.

[The eye and rheumatic diseases].

Kötter I, Huppertz HI.

Z Rheumatol. 2017 Oct;76(8):654-655. doi: 10.1007/s00393-017-0366-5. German. No abstract available.

PMID:
28835971
17.

Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.

Horneff G, Klein A, Klotsche J, Minden K, Huppertz HI, Weller-Heinemann F, Kuemmerle-Deschner J, Haas JP, Hospach A.

Arthritis Res Ther. 2016 Nov 24;18(1):272.

18.

Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review.

Dersch R, Hottenrott T, Schmidt S, Sommer H, Huppertz HI, Rauer S, Meerpohl JJ.

BMC Neurol. 2016 Sep 29;16(1):189.

19.

[Scientific fraud].

Huppertz HI.

Z Rheumatol. 2016 Sep;75(7):654-7. doi: 10.1007/s00393-016-0097-z. German. No abstract available.

PMID:
27312467
20.

Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study.

Gijón M, Bellusci M, Petraitiene B, Noguera-Julian A, Zilinskaite V, Sanchez Moreno P, Saavedra-Lozano J, Glikman D, Daskalaki M, Kaiser-Labusch P, Falup-Pecurariu O, Montagnani C, Prieto L, Gené A, Trumpulyte G, Kulecnikova I, Lepe JA, Cercenado E, Kudinsky R, Makri A, Huppertz HI, Bleotu L, Cocchi P, García-Hierro P, Vitkauskiene A, Fortuny C, Zukovskaja V, Neth O, Santos M, Rokney A, Petra M, Lixandru R, Galli L, Guillén S, Chaves F, Rojo Conejo P.

Clin Microbiol Infect. 2016 Jul;22(7):643.e1-6. doi: 10.1016/j.cmi.2016.04.004. Epub 2016 Apr 21.

21.

[Advances in pediatric rheumatology. Experimental and clinical].

Huppertz HI.

Z Rheumatol. 2016 Apr;75(3):242-4. doi: 10.1007/s00393-016-0062-x. German. No abstract available.

PMID:
26961154
22.

Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.

Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, Jaller Raad JJ, Jarosova K, Anton J, Macku M, Otero Escalante WJ, Rutkowska-Sak L, Trauzeddel R, Velez-Sanchez PJ, Wouters C, Wajdula J, Zang C, Bukowski J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

J Rheumatol. 2016 Apr;43(4):816-24. doi: 10.3899/jrheum.150430. Epub 2016 Mar 1.

PMID:
26932344
23.

Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years.

Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz HI, Job Deslandre C, Minden K, Punaro M, Block AJ, Giannini EH, Martini A; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.

Arthritis Rheumatol. 2015 Oct;67(10):2759-70. doi: 10.1002/art.39234.

24.

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).

Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.

Ann Rheum Dis. 2016 May;75(5):855-61. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. Epub 2015 Apr 29.

PMID:
25926155
25.

Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.

Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.

Arthritis Rheumatol. 2015 May;67(8):2240-9. doi: 10.1002/art.39145.

26.

[Evidence of treatment of chronic inflammation in childhood and adolescence with biologics].

Huppertz HI, Lehmann HW.

Z Rheumatol. 2014 Dec;73(10):907-16. doi: 10.1007/s00393-014-1398-8. German.

PMID:
25479934
27.

[Immunization in children and adolescents with rheumatic and musculoskeletal diseases].

Minden K, Speth F, Huppertz HI, Borte M.

Z Rheumatol. 2014 Dec;73(10):878-89. doi: 10.1007/s00393-014-1396-x. German.

PMID:
25479932
28.

[Identity and cooperation].

Huppertz HI.

Z Rheumatol. 2014 Dec;73(10):876-7. doi: 10.1007/s00393-014-1400-5. German. No abstract available.

PMID:
25373457
29.

[Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Gaubitz M, Dressler F, Huppertz HI, Krause A; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2014 Jun;73(5):469-74. doi: 10.1007/s00393-014-1370-7. German.

PMID:
24924733
30.

Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis.

Glaesener S, Quách TD, Onken N, Weller-Heinemann F, Dressler F, Huppertz HI, Thon A, Meyer-Bahlburg A.

Arthritis Rheumatol. 2014 Sep;66(9):2590-600. doi: 10.1002/art.38736.

31.

Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe.

Huppertz H, Borte M, Schuster V, Giaquinto C, Vesikari T.

Vaccine. 2014 Jul 23;32(34):4243-8. doi: 10.1016/j.vaccine.2014.05.029. Epub 2014 May 20. No abstract available.

PMID:
24852720
32.

Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases.

Sengler C, Niewerth M, Kallinich T, Nimtz-Talaska A, Haller M, Huppertz HI, Minden K.

Clin Rheumatol. 2014 Jan;33(1):137-9. doi: 10.1007/s10067-013-2435-8. Epub 2013 Nov 28.

PMID:
24288046
33.

Prevalence of hepatitis E virus antibodies in children in Germany.

Krumbholz A, Neubert A, Joel S, Girschick H, Huppertz HI, Kaiser P, Liese J, Streng A, Niehues T, Peters J, Sauerbrey A, Schroten H, Tenenbaum T, Wirth S, Zell R, Sauerbrei A.

Pediatr Infect Dis J. 2014 Mar;33(3):258-62. doi: 10.1097/INF.0000000000000077.

PMID:
24168981
34.

Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

Krumbholz A, Neubert A, Girschick H, Huppertz HI, Kaiser P, Liese J, Streng A, Niehues T, Peters J, Sauerbrey A, Schroten H, Tenenbaum T, Wirth S, Sauerbrei A.

Med Microbiol Immunol. 2013 Dec;202(6):417-24. doi: 10.1007/s00430-013-0303-4. Epub 2013 Jun 29.

PMID:
23812435
35.

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, Dolezalova P, Job-Deslandre C, Wulffraat N, Alvarez D, Zang C, Wajdula J, Woodworth D, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2014 Jun;73(6):1114-22. doi: 10.1136/annrheumdis-2012-203046. Epub 2013 May 21.

36.

[Lyme borreliosis in children and adolescents].

Huppertz HI.

Kinderkrankenschwester. 2013 Mar;32(3):108-13. German. No abstract available.

PMID:
23600115
37.

[Juvenile idiopathic arthritis. Thoughts on the current classification].

Huppertz HI.

Z Rheumatol. 2013 May;72(4):329-31. doi: 10.1007/s00393-012-1060-2. German. No abstract available.

PMID:
23435581
38.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. Erratum in: N Engl J Med. 2015 Feb 26;372(9):887.

39.

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, Thon A, Borte M, Ganser G, Trauzeddel R, Huppertz HI.

Arthritis Res Ther. 2012 Oct 24;14(5):R230. doi: 10.1186/ar4072.

40.

[Biologicals for children and adolescents in the treatment of rheumatic diseases].

Huppertz HI.

Z Rheumatol. 2012 Sep;71(7):583-9; quiz 590-1. doi: 10.1007/s00393-012-1011-y. German.

PMID:
22930109
41.

Rotavirus disease in Germany--a prospective survey of very severe cases.

Shai S, Perez-Becker R, von König CH, von Kries R, Heininger U, Forster J, Huppertz HI, Roos R, Göbel U, Niehues T.

Pediatr Infect Dis J. 2013 Feb;32(2):e62-7. doi: 10.1097/INF.0b013e31826f602b.

PMID:
22914558
42.

Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health.

Huppertz HI, Bartmann P, Heininger U, Fingerle V, Kinet M, Klein R, Korenke GC, Nentwich HJ; Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health.

Eur J Pediatr. 2012 Nov;171(11):1619-24. doi: 10.1007/s00431-012-1779-4. Epub 2012 Jul 11.

43.

The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence.

Usonis V, Ivaskeviciene I, Desselberger U, Rodrigo C; Pediatric ROTavirus European CommiTtee (PROTECT).

Vaccine. 2012 Jun 29;30(31):4596-605. doi: 10.1016/j.vaccine.2012.04.097. Epub 2012 May 10. Review.

PMID:
22579864
44.

[Henoch-Schönlein purpura : most frequent form of vasculitis in childhood and adolescence].

Hospach T, Huppertz HI.

Z Rheumatol. 2011 Dec;70(10):829-37. doi: 10.1007/s00393-011-0800-z. German.

PMID:
22139202
45.

[Child and Adolescent Rheumatology].

Huppertz HI.

Z Rheumatol. 2011 Dec;70(10):827-8. doi: 10.1007/s00393-011-0799-1. German. No abstract available.

PMID:
22139201
46.

Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.

von Kries R, Weiss S, Falkenhorst G, Wirth S, Kaiser P, Huppertz HI, Tenenbaum T, Schroten H, Streng A, Liese J, Shai S, Niehues T, Girschick H, Kuscher E, Sauerbrey A, Peters J, Wirsing von König CH, Rückinger S, Hampl W, Michel D, Mertens T.

PLoS One. 2011;6(9):e23955. doi: 10.1371/journal.pone.0023955. Epub 2011 Sep 7.

47.

Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past.

Huppertz HI, Föll D, Girschick H, Minden K, Horneff G.

Rheumatol Int. 2011 Oct;31(10):1259-62. doi: 10.1007/s00296-011-2062-0. Epub 2011 Sep 8. No abstract available.

48.

Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis.

Kaiser P, Borte M, Zimmer KP, Huppertz HI.

Eur J Pediatr. 2012 Feb;171(2):337-45. doi: 10.1007/s00431-011-1536-0. Epub 2011 Aug 11.

PMID:
21833497
49.

[New criteria for the classification of rheumatoid arthritis: significance for child and adolescent rheumatology?].

Huppertz HI.

Z Rheumatol. 2011 Jul;70(5):372-4. doi: 10.1007/s00393-011-0808-4. German. No abstract available.

PMID:
21698476
50.

Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et al.

Huppertz HI.

Arthritis Care Res (Hoboken). 2011 Sep;63(9):1354-5; author reply 1355-6. doi: 10.1002/acr.20521. No abstract available.

Supplemental Content

Loading ...
Support Center